Viewing Study NCT01453842



Ignite Creation Date: 2024-05-05 @ 11:56 PM
Last Modification Date: 2024-10-26 @ 10:42 AM
Study NCT ID: NCT01453842
Status: COMPLETED
Last Update Posted: 2014-12-02
First Post: 2011-10-13

Brief Title: Diet Oil Induced Stimulation of GLP-1
Sponsor: University of Copenhagen
Organization: University of Copenhagen

Study Overview

Official Title: Diet Oil Induced Stimulation of GLP-1
Status: COMPLETED
Status Verified Date: 2014-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Activation of G protein-coupled receptor GPR119 stimulates glucagon-like peptide-1 GLP-1release from the intestinal L-cells Previously administration of 2-oleyl-glycerol 2-OG to humans significantly increased plasma GLP-1 In the present study we want to test the effect in patients with type 2 diabetes The hypothesis is that we will expect to find a significant increased plasma GLP-1 following a meal containing of 2-OG when compared to meals containing of olive oil or carbohydrates alone
Detailed Description: Activation of G protein-coupled receptor GPR119 stimulates glucagon-like peptide-1 GLP-1release from the intestinal L-cells Previously administration of 2-oleyl-glycerol 2-OG to humans significantly increased plasma GLP-1 In the present study we want to test the effect in patients with type 2 diabetes The hypothesis is that we will expect to find a significant increased plasma GLP-1 following a meal containing of 2-OG when compared to meals containing of olive oil or carbohydrates alone The aim of the study is to elucidate the effect of 2-OG diet oil on GLP-1 secretion in patients with type 2 diabetes and to explain the mechanism behind the known stimulation of GLP-1 release by dietary fat

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None